Microbiology
In addition to the comprehensive suite of EQA programs covering microbiology and molecular infectious disease testing, RCPAQAP offers tailored solutions that ensure laboratories maintain the highest standards in diagnostics and patient care.
Our programs are designed to meet global and national regulatory requirements, equipping laboratories with the tools to improve accuracy and performance in critical areas of disease detection.
One key advantage at the RCPAQAP is our ability to rapidly adapt to new threats, which supports laboratories worldwide in maintaining testing accuracy routinely and during recent pandemics.
Are you outside Australia?
Find your local distributorBacterial Serotyping
Catalogue Number
12010102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Lyophilised sampleSample volume
1mLSchedule
February, JulyMeasurand/Test
Serotyping of Streptococcus pneumoniae, Haemophilus influenzae, Neisseria meningitidisStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on August 31, 2023
Bacteriology: Blood Culture Isolates
Catalogue Number
12020102Frequency (No of surveys/year)
4Cases/samples per survey
1Sample Type
Lyophilised sampleSample volume
1mLSchedule
February, April, July, OctoberMeasurand/Test
Blood Culture Isolates, Antimicrobial susceptibility testing (anaerobe)Storage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on August 5, 2024
Bacteriology: Faecal Pathogens
Catalogue Number
12030102Frequency (No of surveys/year)
4Cases/samples per survey
2Sample Type
Lyophilised sampleSample volume
1mLSchedule
February, April, July, OctoberMeasurand/Test
Faecal PathogensStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on May 24, 2023
Bacteriology: Genital Swabs
Catalogue Number
12040102Frequency (No of surveys/year)
4Cases/samples per survey
1Sample Type
Lyophilised sampleSample volume
1mLSchedule
February, April, July, OctoberMeasurand/Test
Genital PathogensStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on May 24, 2023
Bacteriology: Mycobacteriology Acid Fast Smears
Catalogue Number
12050102Frequency (No of surveys/year)
4Cases/samples per survey
2Sample Type
Fixed unstained smear on glass slideSample volume
n/aSchedule
March, June, September, NovemberMeasurand/Test
Acid Fast bacilliStorage and Handling
Upon receipt, store samples at room temperature and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Product details last updated on August 5, 2024
Bacteriology: Mycobacteriology Culture
Catalogue Number
12060102Frequency (No of surveys/year)
4Cases/samples per survey
2Sample Type
Lyophilised sampleSample volume
1mLSchedule
March, June, September, NovemberMeasurand/Test
Mycobacteriology CultureStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on May 24, 2023
Bacteriology: Nose/Throat Pathogens
Catalogue Number
12070102Frequency (No of surveys/year)
4Cases/samples per survey
1Sample Type
Lyophilised sampleSample volume
1mLSchedule
March, June, September, NovemberMeasurand/Test
Nose/Throat PathogensStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on May 24, 2023
Bacteriology: Respiratory Pathogens
Catalogue Number
12080102Frequency (No of surveys/year)
4Cases/samples per survey
2Sample Type
Lyophilised sampleSample volume
1mLSchedule
February, April, July, OctoberMeasurand/Test
Respiratory Pathogens, Antimicrobial susceptibility testingStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on May 24, 2023
Bacteriology: Skin/Eye/Ear Pathogens
Catalogue Number
12090102Frequency (No of surveys/year)
4Cases/samples per survey
1Sample Type
Lyophilised sampleSample volume
1mLSchedule
March, June, September, NovemberMeasurand/Test
Skin/Eye/Ear Pathogens, Antimicrobial susceptibility testingStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on May 24, 2023
Bacteriology: Urine
Catalogue Number
12100102 (1mL) / 12490102 (5mL)Frequency (No of surveys/year)
4Cases/samples per survey
2Sample Type
Lyophilised sampleSample volume
1mL or 5mL optionSchedule
March, June, September, NovemberMeasurand/Test
Simulated clinical material provided to assess urine cell counts (manual and/or automated methods), and the detection and identification of urinary pathogens, bacteria count, and antimicrobial susceptibility testingStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on August 5, 2024
Bacteriology: Wound Anaerobes
Catalogue Number
12110102Frequency (No of surveys/year)
4Cases/samples per survey
1Sample Type
Lyophilised sampleSample volume
1mLSchedule
February, April, July, OctoberMeasurand/Test
Aerobic organisms, Anaerobic organisms, Antimicrobial susceptibility testing (aerobes)Storage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on May 24, 2023
Clostridioides difficile: Laboratory Detection
This unique program serves a global customer base. It combines culture, molecular, and toxin detection, with lyophilised samples ensuring stability, offering comprehensive testing for Clostridioides difficile detection.
Catalogue Number
12120102Frequency (No of surveys/year)
2Cases/samples per survey
4Sample Type
Lyophilised sampleSample volume
2mLSchedule
July, NovemberMeasurand/Test
Detection of Clostridium difficile culture, antigen and toxinStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Detection of Antimicrobial Resistance
This program is designed to identify critical antimicrobial-resistant organisms aligned with Australia’s CARAlert priority organisms. It evaluates laboratories on pathogen identification, resistance mechanisms, susceptibility testing, and overall interpretation (molecular or phenotypic). An effective measure for ensuring complete or referral-based antimicrobial resistance identification.
Catalogue Number
12540102Frequency (No of surveys/year)
2Cases/samples per survey
5Sample Type
Lyophilised sampleSample volume
1mLSchedule
April, SeptemberMeasurand/Test
Simulated clinical material provided to access the detection and identification of Vancomycin-resistant Enterococci (VRE), multi-drug resistant Enterococci, multi-drug resistant Neisseria gonorrhoeae, Multi-drug resistant Shigella and Salmonella, Carbapenem-resistant Enterobacterales (CRE), Carbapenem-resistant Acinetobacter baumannii (CRAB), Carbapenem-resistant Pseudomonas aeruginosa (CRPA) and Candida auris and other resistant bacteria. Molecular testing and antimicrobial susceptibility testing.Storage and Handling
Upon receipt, store samples at 2-8°C. Protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Additional Comments
Antimicrobial resistance (AMR) is a pressing global issue associated with nearly a million deaths annually, projected to exceed ten million by 2050. This program will access the laboratories’ ability to detect and identify significant resistant organisms such as Vancomycin-resistant Enterococci (VRE), Methicillin-resistant Staphylococcus aureus (MRSA), Carbapenem-resistant Enterobacterales (CRE), Carbapenem-resistant Acinetobacter baumannii (CRAB) and others in a clinical setting.
Product details last updated on December 17, 2024
Detection of Mycobacterium chimaera in Heater-Cooler Units (HCUs)
Responding to the global rise in M. chimaera infections linked to cardiopulmonary bypass surgery, this program simulates real-world conditions using in-house lyophilised samples. With protocols aligned to Public Health England and Australian PHLN guidelines, it supports laboratories in identifying contamination risks and enhancing maintenance, cleaning, and disinfection practices for HCUs.
What's new
New for 2025
Catalogue Number
12530102Frequency (No of surveys/year)
1Cases/samples per survey
4Sample Type
Lyophilised sampleSample volume
1 mLSchedule
AprilMeasurand/Test
Simulated clinical material provided to assess the detection and identification of M. chimaera detection in Heater cooler unitsStorage and Handling
Upon receipt, store samples at -20°C. Protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Endoscope and Bronchoscope Surveillance Culture
Catalogue Number
12130102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Lyophilised sampleSample volume
1mLSchedule
March, SeptemberMeasurand/Test
Microbiological Surveillance Culture for endoscopes and bronchoscopesStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on May 24, 2023
Helicobacter pylori Faecal Antigen
Helicobacter pylori is associated with chronic gastritis, peptic ulcers, and gastric cancer, which affect both adult and paediatric populations. Noninvasive diagnostic tests, such as faecal antigen testing, have remarkably high sensitivity and specificity in diagnosing H. pylori infections.
What's new
New for 2025
Catalogue Number
12580102Frequency (No of surveys/year)
2Cases/samples per survey
3Sample Type
Liquid sampleSample volume
1mLSchedule
June, OctoberMeasurand/Test
Simulated clinical material provided to assess the detection of H. pylori faecal antigenStorage and Handling
Upon receipt, store samples at 2-8°C. Protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Alphavirus and Flavivirus
Designed in response to the rise of Alphavirus and Flavivirus cases in the Asia-Pacific region, this program covers a wide range of viruses, including Zika and newly circulating strains like JEV genotype IV. It supports laboratories in ensuring assay accuracy for species differentiation and includes Dengue typing to assess disease severity.
Catalogue Number
12210102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Liquid sampleSample volume
0.25mLSchedule
February, AugustMeasurand/Test
Simulated clinical material provided to assess the detection and identification of Alphaviruses and Flaviviruses using molecular assays. Alphavirus Group, Barmah Forest virus, Chikungunya virus, Ross River virus, Sindbis virus, Flavivirus Group, Dengue virus, Japanese Encephalitis virus, Kunjin virus, Murray Valley Encephalitis virus, Yellow Fever virus, West Nile virus, Zika virusStorage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Dangerous Goods (UN1845)
This survey material was packed in compliance with IATA PI.954 for Dry Ice, UN 1845Product details last updated on December 17, 2024
Molecular Bordetella pertussis
A dedicated program for detecting Bordetella pertussis enhances laboratory testing for this pathogen using single and multiplex testing methods. Differential organisms provide opportunities for challenging specificity, an important aspect affecting patient treatment and outcomes.
Catalogue Number
12220102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Lyophilised sampleSample volume
1mLSchedule
February, OctoberMeasurand/Test
Simulated clinical material provided to assess the detection of Bordetella pertussis including Bordetella parapertussis using molecular assaysStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Chlamydia trachomatis and Neisseria gonorrhoeae
A dual program for the molecular detection of C. trachomatis and N. gonorrhoeae is an essential adjunct to this stalwart testing by many laboratories. This program accommodates protocols for supplemental testing and final interpretation and allows participants to report according to clinical guidelines for N. gonorrhoeae testing.
Catalogue Number
12230102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Lyophilised sampleSample volume
5mLSchedule
March, JulyMeasurand/Test
Simulated clinical material provided to assess the detection of Chlamydia trachomatis and Neisseria gonorrhoeae using molecular assaysStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Coronavirus SARS-CoV-2
Designed to support laboratories in detecting and identifying SARS-CoV-2, this program remains essential for assessing assays against current and evolving strains. It provides simulated respiratory samples to best replicate clinical samples to assess the entire testing process and ensure accurate and reliable patient results. Developed in collaboration with WHO reference laboratories, the program has proven instrumental in identifying key mutations, such as Omicron, and is positioned to meet ongoing and future laboratory needs as the virus evolves, enabling the review and critical analysis of assay target genes.
Catalogue Number
12430102Frequency (No of surveys/year)
4Cases/samples per survey
2Sample Type
Liquid sampleSample volume
1mLSchedule
February, June, August, OctoberMeasurand/Test
Simulated clinical material provided to assess the detection of Coronavirus SARS-CoV-2 using molecular assays with various gene target detectionStorage and Handling
Upon receipt, store samples at -70°C or -20°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN3373Product details last updated on December 17, 2024
Molecular CSF Pathogens
Introduced in 2023, the Molecular CSF Pathogens Program offers a multiplex approach with simulated CSF samples for detecting critical pathogens. With regular updates to include new targets as assays advance, this program ensures laboratories remain equipped for accurate and comprehensive CSF pathogen detection.
Catalogue Number
12500102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Liquid SampleSample volume
0.5mLSchedule
June, AugustMeasurand/Test
Simulated clinical material provided to assess the detection and identification of pathogens in CSF using molecular assays. Cryptococcus spp., Cytomegalovirus, Enterovirus, Haemophilus influenzae, HSV-1/-2, Human herpesvirus 6, Listeria monocytogenes, Neisseria meningitidis, Parechovirus, Streptococcus agalactiae, Streptococcus pneumoniae, Varicella zoster virusStorage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN3373Product details last updated on December 17, 2024
Molecular Cytomegalovirus
Refined in 2022 to use liquid plasma for a closer representation of real samples, the Molecular Cytomegalovirus Program addresses the critical challenge of standardising CMV viral load reporting. By identifying variations in testing methods and assay standards, this program educates participants and drives progress toward achieving consistency in diagnostic practices, ensuring reliability and accuracy in CMV DNA testing.
Catalogue Number
12240102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
PlasmaSample volume
1.2mLSchedule
April, SeptemberMeasurand/Test
Clinical material provided to assess the qualitative and quantitative detection of CMV DNA. CMV Qualitative DNA, CMV Quantitative DNA, CMV Viral loadStorage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Dangerous Goods (UN1845)
This survey material was packed in compliance with IATA PI.954 for Dry Ice, UN 1845Product details last updated on December 17, 2024
Molecular Dermatophytes
This program evaluates molecular identification of a comprehensive range of dermatophytes, including Microsporum spp., Trichophyton spp., Nannizzia spp. and Epidermophyton spp., transitioning from morphology-based to molecular testing. Mixed and individual isolates included in this program provide laboratories with real-life challenges reflecting testing using multiplexed assays
What's new
New for 2025
Catalogue Number
12590102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Liquid sampleSample volume
1mLSchedule
June, NovemberMeasurand/Test
Simulated clinical material provided to assess the detection and identification of dermatophytes causing onychomycosis using molecular methods.Storage and Handling
Upon receipt, store samples at 2-8°C. Protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Enterovirus
The program features both Enterovirus and Coxsackieviruses for detection and also includes differential pathogens, including Rhinovirus and Parechovirus to determine assay specificity. An important laboratory test, particularly in children, this program is formulated to ensure accurate and reliable testing.
Catalogue Number
12250102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Lyophilised sampleSample volume
1mLSchedule
March, JulyMeasurand/Test
Simulated clinical material provided to assess the detection of Enteroviruses including Parechovirus using molecular assaysStorage and Handling
Upon receipt, store samples at 2-8 °C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Gastrointestinal Pathogens: Bacteria
This multiplex program features simulated faecal samples designed to feature key enteric bacterial pathogens, including circulating and mixed strains for a realistic testing experience. With tailored panels aligning to bacterial, viral, and parasite assays, this program identifies gaps in assay performance and sparks valuable investigations by manufacturers to refine targets and assays.
Catalogue Number
12260102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Lyophilised sampleSample volume
1mLSchedule
February, JulyMeasurand/Test
Simulated clinical material provided to assess the detection of Gastrointestinal Bacteria Pathogens using molecular assays. Clinical material examples include: Aeromonas hydrophila, Campylobacter spp., Plesiomonas spp, Salmonella spp, Shigella spp, Vibrio spp, Yersinia sppStorage and Handling
Upon receipt, store samples at 2-8 °C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Gastrointestinal Pathogens: Parasites
This multiplex program features simulated faecal samples designed to feature key enteric parasitic pathogens, including circulating and mixed strains for a realistic testing experience. With tailored panels aligning to bacterial, viral, and parasite assays, this program identifies gaps in assay performance and sparks valuable investigations by manufacturers to refine targets and assays.
Catalogue Number
12270102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Liquid sampleSample volume
1mLSchedule
March, NovemberMeasurand/Test
Simulated clinical material provided to assess the detection of Gastrointestinal Parasite Pathogens using molecular assays. Clinical material examples include: Blastocystis hominis, Cryptosporidium spp, Dientamoeba fragilis, Entamoeba histolytica, Giardia sppStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Gastrointestinal Pathogens: Viral
This multiplex program features simulated faecal samples designed to feature key enteric viral pathogens, including circulating and mixed strains for a realistic testing experience. With tailored panels aligning to bacterial, viral, and parasite assays, this program identifies gaps in assay performance and sparks valuable investigations by manufacturers to refine targets and assays.
Catalogue Number
12280102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Liquid sampleSample volume
0.5mLSchedule
April, JulyMeasurand/Test
Simulated clinical material provided to assess the detection of Gastrointestinal Viral Pathogens using molecular assays. Clinical material examples include: Adenovirus, Astrovirus, Norovirus, Rotavirus, SapovirusStorage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Hepatitis B Virus DNA
Designed to include a range of DNA levels and diverse genotypes, this program has driven the standardisation of viral load reporting, directly enhancing treatment outcomes. It ensures consistency and reliability in diagnostics while staying at the forefront of advancements in hepatitis testing.
Catalogue Number
12290102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
PlasmaSample volume
1.2mLSchedule
February, AugustMeasurand/Test
Clinical material provided to assess the qualitative and quantitative detection of Hepatitis B DNA. HBV Qualitative DNA, HBV Quantitative DNA, HBV Viral loadStorage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Dangerous Goods (UN1845)
This survey material was packed in compliance with IATA PI.954 for Dry Ice, UN 1845Product details last updated on December 17, 2024
Molecular Hepatitis C Virus RNA
Designed to include a range of RNA levels and diverse genotypes, this program has driven the standardisation of viral load reporting, directly enhancing treatment outcomes. It ensures consistency and reliability in diagnostics while staying at the forefront of advancements in hepatitis testing.
Catalogue Number
12300102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
PlasmaSample volume
1.2mLSchedule
February, JulyMeasurand/Test
Clinical material provided to assess the qualitative and quantitative detection of Hepatitis C RNA. HCV Qualitative RNA, HCV Quantitative RNA, HCV Viral loadStorage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Dangerous Goods (UN1845)
This survey material was packed in compliance with IATA PI.954 for Dry Ice, UN 1845Product details last updated on December 17, 2024
Molecular Hepatitis C Virus RNA Genotyping
Featuring a wide array of HCV genotypes, this program evolves to keep pace with advancements in assay automation and progresses toward standardised reporting. Ensuring accurate genotype identification and reliable result interpretation, this program enables laboratories to support effective patient care.
Catalogue Number
12310102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
PlasmaSample volume
1.2mLSchedule
April, SeptemberMeasurand/Test
Clinical material provided to assess the genotyping of Hepatitis C virusStorage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Dangerous Goods (UN1845)
This survey material was packed in compliance with IATA PI.954 for Dry Ice, UN 1845Product details last updated on December 17, 2024
Molecular HIV-1 RNA
Designed to include a range of RNA levels, this program has driven the standardisation of HIV viral load reporting, directly enhancing treatment outcomes and ensuring consistency and reliability in diagnostics.
Catalogue Number
12330102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
PlasmaSample volume
1.2mLSchedule
April, SeptemberMeasurand/Test
Clinical material provided to assess the qualitative and quantitative detection of HIV RNA. HIV Qualitative RNA, HIV-1 RNA Quantitative, HIV Viral loadStorage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Dangerous Goods (UN1845)
This survey material was packed in compliance with IATA PI.954 for Dry Ice, UN 1845Product details last updated on December 17, 2024
Molecular HSV/VZV
This program was developed by combining two programs to replicate the syndromic assessment of vesicle fluid for HSV and VZV. It enables pathogen detection, identification and differentiation of these human herpes viruses ensuring reliable patient results and clinical outcomes.
What's new
New for 2024
Catalogue Number
12560102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Liquid sampleSample volume
0.5 mLSchedule
April, OctoberMeasurand/Test
Simulated clinical material provided to assess the detection and identification of HSV-1, HSV-2 and Varicella zoster virus using molecular assays.Storage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Human Papillomavirus DNA
Utilising clinical samples that mimic real patient scenarios, this program challenges internal cell controls and accounts for contaminating factors including blood. Developed in close collaboration with WHO collaborating laboratories, it provides comprehensive coverage of different HPV risk groups and genotypes, ensuring accurate and reliable diagnostics.
Catalogue Number
12340102Frequency (No of surveys/year)
4Cases/samples per survey
3Sample Type
PreservCyt® solutionSample volume
2mL (4mL hc2/Cervista)Schedule
February, May, July, SeptemberMeasurand/Test
Clinical material provided to assess the detection and typing of high risk HPV DNA using molecular assays.Storage and Handling
Upon receipt, store samples at 2-8°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Influenza
Stay prepared for influenza outbreaks with the comprehensive Molecular Influenza Program. Expanding on targeted H5 and H1N1pdm programs, this combined offering now covers all influenza strains for detection and typing. Developed in close collaboration with WHO reference laboratories, it ensures the inclusion of currently circulating strains, providing laboratories with the tools to deliver precise and timely influenza diagnostics.
Catalogue Number
12350102Frequency (No of surveys/year)
3Cases/samples per survey
6Sample Type
Liquid sampleSample volume
1mLSchedule
March, May, AugustMeasurand/Test
Simulated clinical material provided to assess the detection and typing of Influenza using molecular assays. Influenza A Matrix, Influenza A H1, Influenza A H1 (pandemic), Influenza A H3, Influenza A H5, Influenza A H7, Influenza A H9, Influenza A N1 (avian), Influenza A N1 (pandemic), Influenza BStorage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Malaria
The Molecular Malaria program for the detection of malarial DNA features a simulated whole blood sample designed to closely mimic a clinical sample. It allows for the rapid detection of malarial species by molecular techniques and typing to species level. This program has already uncovered critical risks, such as carry-over contamination in molecular techniques, empowering laboratories to refine their practices and enhance diagnostic accuracy.
Catalogue Number
12470102Frequency (No of surveys/year)
2Cases/samples per survey
2Sample Type
Whole Blood sampleSample volume
600µLSchedule
April, AugustMeasurand/Test
Simulated clinical material provided to assess the molecular detection of Plasmodium spp.Storage and Handling
Upon receipt, store samples at 2-8°C. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular mec A/nuc gene
This program offers an essential tool to ensure the accurate detection and identification of MRSA pathogens in the laboratory. It accommodates a wide range of testing assays, focusing on the mec A and nuc gene targets. It also allows for comparisons with other assay groups and within the same groups, which is paramount to ensuring these important pathogens are correctly reported.
Catalogue Number
12370102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Lyophilised sampleSample volume
1mLSchedule
February, OctoberMeasurand/Test
Simulated clinical material provided to assess the detection of MRSA (mecA/nuc genes) using molecular assaysStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Mycobacterium tuberculosis and M. avium complex
This program is essential for the molecular detection of Mycobacterium tuberculosis and features M. avium complex, an important differential organism.
Catalogue Number
12360102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Lyophilised sampleSample volume
1mLSchedule
April, SeptemberMeasurand/Test
Simulated clinical material provided to assess the detection of Mycobacterium tuberculosis & Mycobacterium avium complex and rifampicin resistance in M. tuberculosis complex using molecular assaysStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Neisseria meningitidis
This program focuses on the molecular detection of Neisseria meningitidis and includes various types to challenge laboratories with this important pathogen to ensure reliable and accurate patient results.
Catalogue Number
12380102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Lyophilised sampleSample volume
1mLSchedule
February, JuneMeasurand/Test
Simulated clinical material provided to assess the detection of Neisseria meningitidis using molecular assaysStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Rapid Diagnostics Influenza/RSV/SARS-CoV-2
The Molecular Rapid Diagnostics program is designed to detect and identify Influenza A and B, RSV, and SARS-CoV-2 using rapid molecular assays. It features a reduced panel of current circulating strains and a shorter survey time to simulate real-world clinical testing using these assays.
Catalogue Number
12390102Frequency (No of surveys/year)
3Cases/samples per survey
4Sample Type
Liquid sampleSample volume
1mLSchedule
April, May, AugustMeasurand/Test
Simulated clinical material provided to assess the detection of Influenza, RSV and SARS-CoV-2 using molecular rapid detection methods. Influenza A, Influenza B, RSV and SARS-CoV-2Storage and Handling
Upon receipt, store samples at -70°C or -20°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Respiratory Pathogens
This program is designed to be a true syndromic testing experience, featuring over 40 pathogens, including various virus types and bacterial strains. It allows for multiple testing platforms and assays and enables participants to identify and differentiate pathogens that would be experienced clinically. Continuous development enables this program to remain clinically relevant and expand to participant needs to continuously keep patient care at the forefront of mind.
Catalogue Number
12400102Frequency (No of surveys/year)
3Cases/samples per survey
6Sample Type
Liquid sampleSample volume
0.5mLSchedule
March, June, SeptemberMeasurand/Test
Simulated clinical material provided to assess the detection and identification of Respiratory Pathogens using molecular assays. Multiplex Assays, surveys can include Adenovirus, Bocavirus, Bordetella pertusssis, Bordetella parapertussis, Chlamydophila pneumoniae, Coronavirus (229E, HKU1, OC43, NL63, SARS-CoV-2), Enterovirus, human Metapneumovirus, Haemophilus influenzae, Influenza, Legionella pneumoniae, Mycoplasma pneumoniae, Parechovirus, Parainfluenza 1-4, Pneumocystis jirovecii, Rhinovirus, RSV, Streptococcus pneumoniaeStorage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Sexually Transmitted Pathogens
This program, developed in 2022, features simulated swabs and urine samples and expands routine testing beyond Ct/Ng to a broader range of STIs. It can detect drug-resistant organisms, enabling laboratories to stay ahead in identifying and addressing emerging challenges in STI diagnostics.
Catalogue Number
12480102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Liquid sampleSample volume
2mLSchedule
May, OctoberMeasurand/Test
Simulated clinical material provided to assess the detection and identification of Sexually Transmitted Pathogens using molecular assays. Multiplex Assays, Chlamydia trachomatis, Herpes Simplex Virus, Mycoplasma genitalium, Neisseria gonorrhoeae, Treponema pallidum, Trichomonas vaginalis.Storage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Molecular Strongyloides
This program provides simulated samples, developed in collaboration with world-leading experts, to ensure accurate DNA detection of the presence of Strongyloides spp. in faecal specimens. One of only two global offerings, it supports laboratories in maintaining proficiency in identifying this challenging pathogen.
What's new
New for 2025
Catalogue Number
12520102Frequency (No of surveys/year)
2Cases/samples per survey
3Sample Type
Lyophilised SampleSample volume
200µLSchedule
April, OctoberMeasurand/Test
Simulated clinical material provided to assess the detection of Strongyloides using molecular assaysStorage and Handling
Upon receipt, store samples at -20°C. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN3373Product details last updated on December 17, 2024
Molecular Vaccine Preventable Pathogens
This program features vaccine-preventable pathogens such as measles, mumps, and rubella. It also includes other pathogens for differential identification, including VZV and influenza. A dedicated program for these pathogens allows improved coverage, enhancing laboratory testing confidence.
Catalogue Number
12410102Frequency (No of surveys/year)
2Cases/samples per survey
6Sample Type
Liquid sampleSample volume
0.5mLSchedule
May, AugustMeasurand/Test
Simulated clinical material provided to assess the detection and identification of Vaccine Preventable Pathogens using molecular assays. Multiplex Assays, Bordetella sp, Influenza A/B, Measles, Mumps, Rubella, Varicella zoster virusStorage and Handling
Upon receipt, store samples at -70°CDangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Mycology
This program offers detailed grading for identification and antifungal susceptibility testing, with expert commentary highlighting laboratory performance and potential issues. Annual updates to mycological nomenclature by the Australian Mycology Reference Laboratory ensure participants stay current. It also provides critical advice and education to address errors in methodology and interpretation.
Catalogue Number
12140102Frequency (No of surveys/year)
4Cases/samples per survey
3Sample Type
LiquidSample volume
1mLSchedule
March, June, September, NovemberMeasurand/Test
Dermatophytes, systemic mycotic pathogens, clinically significant yeast and contaminants of interest. Susceptibility testing of yeasts and aspergillus species.Storage and Handling
Upon receipt, store samples at room temperature and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Non-tuberculous mycobacteria (NTM)
Nontuberculous Mycobacteria (NTM) are categorised into slow-growing and rapid-growing, and both cause acute and chronic disease in immunocompromised and immunocompetent individuals. Accurate and timely diagnosis of these pathogens is necessary to limit the progression of pulmonary disease, lymphadenitis, cutaneous disease, and life-threatening disseminated disease in patients.
Catalogue Number
12460102Frequency (No of surveys/year)
2Cases/samples per survey
3 samples per surveySample Type
Lyophilised bacteriaSample volume
1mLSchedule
March, SeptemberMeasurand/Test
Simulated clinical material provided to assess the detection of Non-tuberculous MycobacteriaStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on December 17, 2024
Parasitology
Catalogue Number
12160102Frequency (No of surveys/year)
4Cases/samples per survey
2Sample Type
Fixed faecal suspensions or unstained glass slideSample volume
1mLSchedule
February, April, July, OctoberMeasurand/Test
Faecal samples containing protozoa, helminths and faecal artefacts for parasitic staining and microscopy.Storage and Handling
Upon receipt, store samples at room temperature and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Product details last updated on August 5, 2024
STAT Microscopy: Gram Stain
Catalogue Number
12440102Frequency (No of surveys/year)
4Cases/samples per survey
2Sample Type
Unstained glass slidesSchedule
February, April, July, OctoberMeasurand/Test
Gram stainStorage and Handling
Upon receipt, store samples at room temperature. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Product details last updated on August 5, 2024
STAT Microscopy: Urine Microscopy
Catalogue Number
12170102 (1mL) / 12170502 (5mL)Frequency (No of surveys/year)
4Cases/samples per survey
2Sample Type
Lyophilised samplesSample volume
1mL or 5mL optionsSchedule
February, April, July, OctoberMeasurand/Test
Simulated clinical material provided to assess the detection of urine cell counts (manual and/or automated methods)Storage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Product details last updated on August 5, 2024
Streptococcus pneumoniae: urinary antigen detection
Catalogue Number
12180102Frequency (No of surveys/year)
2Cases/samples per survey
4Sample Type
Lyophilised sampleSample volume
1mLSchedule
April, OctoberMeasurand/Test
Detection of pneumococcal urinary antigenStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Dangerous Goods (UN3373)
This survey material was packed in compliance with IATA PI.650 for Biological Substance Category B, UN 3373Product details last updated on August 5, 2024
Urine Dipstick Chemistry
Catalogue Number
12190102Frequency (No of surveys/year)
4Cases/samples per survey
2Sample Type
Lyophilised sampleSample volume
10mLSchedule
March, June, September, NovemberMeasurand/Test
Leukocyte esterase, Blood, Glucose, Protein, Nitrite, Ascorbic acid, pHStorage and Handling
Upon receipt, store samples at 2-8°C and protect from direct light. Testing within 24-48 hours is recommended to reduce the risk of sample deterioration.Product details last updated on August 5, 2024
<
>